<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02768168</url>
  </required_header>
  <id_info>
    <org_study_id>mz2016</org_study_id>
    <nct_id>NCT02768168</nct_id>
  </id_info>
  <brief_title>The Effects of Dezocine Pretreatment on Dexamethasone Induced Perineal Irritation</brief_title>
  <official_title>The Effects of Dezocine Pretreatment on Dexamethasone Induced Perineal Irritation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital of Ningxia Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Hospital of Ningxia Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the efficacy of dezocine pretreatment on
      dexamethasone 21-phosphate induced perineal irritation (include pian and pruritus).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dexamethasone is a synthetic glucocorticoid, which may cause perineal irritation when given
      intravenously. The major clinical manifestations are pruritus and pain，and the incidence vary
      between 38%-71%. Some patients undergo spontaneous remission, while others develop into
      severe pain or pruritus. Dezocine, a new synthetic opiate agonist-antagonist, has been used
      for the treatment of pain and pruritus, but its role in relieving dexamethasone induced
      perineal irritation has not been studied yet. The aim of this study was to investigate the
      efficacy of dezocine pretreatment on dexamethasone induced perineal irritation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The occurrence of perineal irritation after the injection of dexamethasone 21-phosphate among Group D (40 patients receive dezocine 0.1 mg/Kg) and Group C (40 patients receive matching placebo)</measure>
    <time_frame>In the first 3 min period after the injection of dexamethasone 21-phosphate phosphate</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The severity of perineal irritation after the injection of dexamethasone 21-phosphate among Group D (40 patients receive dezocine 0.1 mg/Kg) and Group C (40 patients receive matching placebo)</measure>
    <time_frame>In the first 3 min period after the injection of dexamethasone 21-phosphate phosphate</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>The duration of perineal irritation after the injection of dexamethasone 21-phosphate among Group D (40 patients receive dezocine 0.1 mg/Kg) and Group C (40 patients receive matching placebo)</measure>
    <time_frame>In the first 3 min period after the injection of dexamethasone 21-phosphate phosphate</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Adverse Effect</condition>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>40 patients receive dezocine 0.1 mg/Kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>40 patients receive matching placebo （normal saline）</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dezocine</intervention_name>
    <description>receive dezocine 0.1 mg/kg</description>
    <arm_group_label>Group D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>receive matching placebo (equal volume of normal saline)</description>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18-65 years

          -  ASA physical status I-II

          -  BMI 18-24.5 kg/m2

        Exclusion Criteria:

          -  On regular use of analgesic

          -  Contraindication or allergy to steroid or dezocine

          -  Drug or alcohol abuse

          -  Diagnosed with paresthesia or mental diseases

          -  Communication disorders

          -  Pregnancy or nursing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Junwei Zheng</last_name>
    <role>Principal Investigator</role>
    <affiliation>General Hospital of Ningxia Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>General Hospital of Ningxia Medical University</name>
      <address>
        <city>Yinchuan</city>
        <state>Ningxia</state>
        <zip>750004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2016</study_first_submitted>
  <study_first_submitted_qc>May 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2016</study_first_posted>
  <last_update_submitted>August 2, 2016</last_update_submitted>
  <last_update_submitted_qc>August 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dezocine</keyword>
  <keyword>Dexamethasone 21-phosphate</keyword>
  <keyword>Pain</keyword>
  <keyword>Pruritus</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dezocine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>September 26, 2016</submitted>
    <returned>November 14, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

